1 Study Coverage
    1.1 Frovatriptan Product Introduction
    1.2 Market by Type
        1.2.1 Global Frovatriptan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hospital
        1.2.3 Drug Store
    1.3 Market by Application
        1.3.1 Global Frovatriptan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Menstrual Migraines
        1.3.3 Migraine with Aura
        1.3.4 Migraine without Aura
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Frovatriptan Sales Estimates and Forecasts 2017-2028
    2.2 Global Frovatriptan Revenue Estimates and Forecasts 2017-2028
    2.3 Global Frovatriptan Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Frovatriptan Sales by Region
        2.4.1 Global Frovatriptan Sales by Region (2017-2022)
        2.4.2 Global Sales Frovatriptan by Region (2023-2028)
    2.5 Global Frovatriptan Revenue by Region
        2.5.1 Global Frovatriptan Revenue by Region (2017-2022)
        2.5.2 Global Frovatriptan Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Frovatriptan Sales by Manufacturers
        3.1.1 Global Top Frovatriptan Manufacturers by Sales (2017-2022)
        3.1.2 Global Frovatriptan Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Frovatriptan in 2021
    3.2 Global Frovatriptan Revenue by Manufacturers
        3.2.1 Global Frovatriptan Revenue by Manufacturers (2017-2022)
        3.2.2 Global Frovatriptan Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Frovatriptan Revenue in 2021
    3.3 Global Frovatriptan Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Frovatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Frovatriptan Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Frovatriptan Sales by Type
        4.1.1 Global Frovatriptan Historical Sales by Type (2017-2022)
        4.1.2 Global Frovatriptan Forecasted Sales by Type (2023-2028)
        4.1.3 Global Frovatriptan Sales Market Share by Type (2017-2028)
    4.2 Global Frovatriptan Revenue by Type
        4.2.1 Global Frovatriptan Historical Revenue by Type (2017-2022)
        4.2.2 Global Frovatriptan Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Frovatriptan Revenue Market Share by Type (2017-2028)
    4.3 Global Frovatriptan Price by Type
        4.3.1 Global Frovatriptan Price by Type (2017-2022)
        4.3.2 Global Frovatriptan Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Frovatriptan Sales by Application
        5.1.1 Global Frovatriptan Historical Sales by Application (2017-2022)
        5.1.2 Global Frovatriptan Forecasted Sales by Application (2023-2028)
        5.1.3 Global Frovatriptan Sales Market Share by Application (2017-2028)
    5.2 Global Frovatriptan Revenue by Application
        5.2.1 Global Frovatriptan Historical Revenue by Application (2017-2022)
        5.2.2 Global Frovatriptan Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Frovatriptan Revenue Market Share by Application (2017-2028)
    5.3 Global Frovatriptan Price by Application
        5.3.1 Global Frovatriptan Price by Application (2017-2022)
        5.3.2 Global Frovatriptan Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Frovatriptan Market Size by Type
        6.1.1 North America Frovatriptan Sales by Type (2017-2028)
        6.1.2 North America Frovatriptan Revenue by Type (2017-2028)
    6.2 North America Frovatriptan Market Size by Application
        6.2.1 North America Frovatriptan Sales by Application (2017-2028)
        6.2.2 North America Frovatriptan Revenue by Application (2017-2028)
    6.3 North America Frovatriptan Market Size by Country
        6.3.1 North America Frovatriptan Sales by Country (2017-2028)
        6.3.2 North America Frovatriptan Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Frovatriptan Market Size by Type
        7.1.1 Europe Frovatriptan Sales by Type (2017-2028)
        7.1.2 Europe Frovatriptan Revenue by Type (2017-2028)
    7.2 Europe Frovatriptan Market Size by Application
        7.2.1 Europe Frovatriptan Sales by Application (2017-2028)
        7.2.2 Europe Frovatriptan Revenue by Application (2017-2028)
    7.3 Europe Frovatriptan Market Size by Country
        7.3.1 Europe Frovatriptan Sales by Country (2017-2028)
        7.3.2 Europe Frovatriptan Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Frovatriptan Market Size by Type
        8.1.1 Asia Pacific Frovatriptan Sales by Type (2017-2028)
        8.1.2 Asia Pacific Frovatriptan Revenue by Type (2017-2028)
    8.2 Asia Pacific Frovatriptan Market Size by Application
        8.2.1 Asia Pacific Frovatriptan Sales by Application (2017-2028)
        8.2.2 Asia Pacific Frovatriptan Revenue by Application (2017-2028)
    8.3 Asia Pacific Frovatriptan Market Size by Region
        8.3.1 Asia Pacific Frovatriptan Sales by Region (2017-2028)
        8.3.2 Asia Pacific Frovatriptan Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Frovatriptan Market Size by Type
        9.1.1 Latin America Frovatriptan Sales by Type (2017-2028)
        9.1.2 Latin America Frovatriptan Revenue by Type (2017-2028)
    9.2 Latin America Frovatriptan Market Size by Application
        9.2.1 Latin America Frovatriptan Sales by Application (2017-2028)
        9.2.2 Latin America Frovatriptan Revenue by Application (2017-2028)
    9.3 Latin America Frovatriptan Market Size by Country
        9.3.1 Latin America Frovatriptan Sales by Country (2017-2028)
        9.3.2 Latin America Frovatriptan Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Frovatriptan Market Size by Type
        10.1.1 Middle East and Africa Frovatriptan Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Frovatriptan Revenue by Type (2017-2028)
    10.2 Middle East and Africa Frovatriptan Market Size by Application
        10.2.1 Middle East and Africa Frovatriptan Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Frovatriptan Revenue by Application (2017-2028)
    10.3 Middle East and Africa Frovatriptan Market Size by Country
        10.3.1 Middle East and Africa Frovatriptan Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Frovatriptan Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Ligand Pharmaceuticals
        11.1.1 Ligand Pharmaceuticals Corporation Information
        11.1.2 Ligand Pharmaceuticals Overview
        11.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Ligand Pharmaceuticals Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Ligand Pharmaceuticals Recent Developments
    11.2 Endo Pharmaceuticals
        11.2.1 Endo Pharmaceuticals Corporation Information
        11.2.2 Endo Pharmaceuticals Overview
        11.2.3 Endo Pharmaceuticals Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Endo Pharmaceuticals Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Endo Pharmaceuticals Recent Developments
    11.3 Doc Generici
        11.3.1 Doc Generici Corporation Information
        11.3.2 Doc Generici Overview
        11.3.3 Doc Generici Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Doc Generici Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Doc Generici Recent Developments
    11.4 Menarini
        11.4.1 Menarini Corporation Information
        11.4.2 Menarini Overview
        11.4.3 Menarini Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Menarini Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Menarini Recent Developments
    11.5 Novartis
        11.5.1 Novartis Corporation Information
        11.5.2 Novartis Overview
        11.5.3 Novartis Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Novartis Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Novartis Recent Developments
    11.6 Almac
        11.6.1 Almac Corporation Information
        11.6.2 Almac Overview
        11.6.3 Almac Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Almac Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Almac Recent Developments
    11.7 Glenmark Generics
        11.7.1 Glenmark Generics Corporation Information
        11.7.2 Glenmark Generics Overview
        11.7.3 Glenmark Generics Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Glenmark Generics Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Glenmark Generics Recent Developments
    11.8 Teva
        11.8.1 Teva Corporation Information
        11.8.2 Teva Overview
        11.8.3 Teva Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Teva Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Teva Recent Developments
    11.9 Zambon
        11.9.1 Zambon Corporation Information
        11.9.2 Zambon Overview
        11.9.3 Zambon Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Zambon Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Zambon Recent Developments
    11.10 Apotex
        11.10.1 Apotex Corporation Information
        11.10.2 Apotex Overview
        11.10.3 Apotex Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Apotex Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Apotex Recent Developments
    11.11 G.L. Pharma
        11.11.1 G.L. Pharma Corporation Information
        11.11.2 G.L. Pharma Overview
        11.11.3 G.L. Pharma Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 G.L. Pharma Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 G.L. Pharma Recent Developments
    11.12 Chanelle Pharma
        11.12.1 Chanelle Pharma Corporation Information
        11.12.2 Chanelle Pharma Overview
        11.12.3 Chanelle Pharma Frovatriptan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Chanelle Pharma Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Chanelle Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Frovatriptan Industry Chain Analysis
    12.2 Frovatriptan Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Frovatriptan Production Mode & Process
    12.4 Frovatriptan Sales and Marketing
        12.4.1 Frovatriptan Sales Channels
        12.4.2 Frovatriptan Distributors
    12.5 Frovatriptan Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Frovatriptan Industry Trends
    13.2 Frovatriptan Market Drivers
    13.3 Frovatriptan Market Challenges
    13.4 Frovatriptan Market Restraints
14 Key Findings in The Global Frovatriptan Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Frovatriptan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Hospital
    Table 3. Major Manufacturers of Drug Store
    Table 4. Global Frovatriptan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Frovatriptan Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Frovatriptan Sales by Region (2017-2022) & (K Units)
    Table 7. Global Frovatriptan Sales Market Share by Region (2017-2022)
    Table 8. Global Frovatriptan Sales by Region (2023-2028) & (K Units)
    Table 9. Global Frovatriptan Sales Market Share by Region (2023-2028)
    Table 10. Global Frovatriptan Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Frovatriptan Revenue Market Share by Region (2017-2022)
    Table 12. Global Frovatriptan Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Frovatriptan Revenue Market Share by Region (2023-2028)
    Table 14. Global Frovatriptan Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Frovatriptan Sales Share by Manufacturers (2017-2022)
    Table 16. Global Frovatriptan Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Frovatriptan Revenue Share by Manufacturers (2017-2022)
    Table 18. Frovatriptan Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Frovatriptan Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Frovatriptan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frovatriptan as of 2021)
    Table 21. Frovatriptan Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Frovatriptan Product Offered
    Table 23. Date of Manufacturers Enter into Frovatriptan Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Frovatriptan Sales by Type (2017-2022) & (K Units)
    Table 26. Global Frovatriptan Sales by Type (2023-2028) & (K Units)
    Table 27. Global Frovatriptan Sales Share by Type (2017-2022)
    Table 28. Global Frovatriptan Sales Share by Type (2023-2028)
    Table 29. Global Frovatriptan Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Frovatriptan Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Frovatriptan Revenue Share by Type (2017-2022)
    Table 32. Global Frovatriptan Revenue Share by Type (2023-2028)
    Table 33. Frovatriptan Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Frovatriptan Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Frovatriptan Sales by Application (2017-2022) & (K Units)
    Table 36. Global Frovatriptan Sales by Application (2023-2028) & (K Units)
    Table 37. Global Frovatriptan Sales Share by Application (2017-2022)
    Table 38. Global Frovatriptan Sales Share by Application (2023-2028)
    Table 39. Global Frovatriptan Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Frovatriptan Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Frovatriptan Revenue Share by Application (2017-2022)
    Table 42. Global Frovatriptan Revenue Share by Application (2023-2028)
    Table 43. Frovatriptan Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Frovatriptan Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Frovatriptan Sales by Type (2017-2022) & (K Units)
    Table 46. North America Frovatriptan Sales by Type (2023-2028) & (K Units)
    Table 47. North America Frovatriptan Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Frovatriptan Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Frovatriptan Sales by Application (2017-2022) & (K Units)
    Table 50. North America Frovatriptan Sales by Application (2023-2028) & (K Units)
    Table 51. North America Frovatriptan Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Frovatriptan Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Frovatriptan Sales by Country (2017-2022) & (K Units)
    Table 54. North America Frovatriptan Sales by Country (2023-2028) & (K Units)
    Table 55. North America Frovatriptan Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Frovatriptan Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Frovatriptan Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Frovatriptan Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Frovatriptan Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Frovatriptan Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Frovatriptan Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Frovatriptan Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Frovatriptan Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Frovatriptan Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Frovatriptan Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Frovatriptan Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Frovatriptan Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Frovatriptan Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Frovatriptan Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Frovatriptan Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Frovatriptan Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Frovatriptan Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Frovatriptan Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Frovatriptan Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Frovatriptan Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Frovatriptan Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Frovatriptan Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Frovatriptan Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Frovatriptan Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Frovatriptan Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Frovatriptan Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Frovatriptan Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Frovatriptan Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Frovatriptan Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Frovatriptan Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Frovatriptan Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Frovatriptan Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Frovatriptan Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Frovatriptan Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Frovatriptan Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Frovatriptan Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Frovatriptan Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Frovatriptan Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Frovatriptan Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Frovatriptan Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Frovatriptan Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Frovatriptan Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Frovatriptan Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Frovatriptan Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Frovatriptan Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Frovatriptan Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Frovatriptan Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Frovatriptan Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Frovatriptan Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Ligand Pharmaceuticals Corporation Information
    Table 106. Ligand Pharmaceuticals Description and Major Businesses
    Table 107. Ligand Pharmaceuticals Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Ligand Pharmaceuticals Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Ligand Pharmaceuticals Recent Developments
    Table 110. Endo Pharmaceuticals Corporation Information
    Table 111. Endo Pharmaceuticals Description and Major Businesses
    Table 112. Endo Pharmaceuticals Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Endo Pharmaceuticals Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Endo Pharmaceuticals Recent Developments
    Table 115. Doc Generici Corporation Information
    Table 116. Doc Generici Description and Major Businesses
    Table 117. Doc Generici Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Doc Generici Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Doc Generici Recent Developments
    Table 120. Menarini Corporation Information
    Table 121. Menarini Description and Major Businesses
    Table 122. Menarini Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Menarini Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Menarini Recent Developments
    Table 125. Novartis Corporation Information
    Table 126. Novartis Description and Major Businesses
    Table 127. Novartis Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Novartis Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Novartis Recent Developments
    Table 130. Almac Corporation Information
    Table 131. Almac Description and Major Businesses
    Table 132. Almac Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Almac Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Almac Recent Developments
    Table 135. Glenmark Generics Corporation Information
    Table 136. Glenmark Generics Description and Major Businesses
    Table 137. Glenmark Generics Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Glenmark Generics Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Glenmark Generics Recent Developments
    Table 140. Teva Corporation Information
    Table 141. Teva Description and Major Businesses
    Table 142. Teva Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Teva Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Teva Recent Developments
    Table 145. Zambon Corporation Information
    Table 146. Zambon Description and Major Businesses
    Table 147. Zambon Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Zambon Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Zambon Recent Developments
    Table 150. Apotex Corporation Information
    Table 151. Apotex Description and Major Businesses
    Table 152. Apotex Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Apotex Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Apotex Recent Developments
    Table 155. G.L. Pharma Corporation Information
    Table 156. G.L. Pharma Description and Major Businesses
    Table 157. G.L. Pharma Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. G.L. Pharma Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. G.L. Pharma Recent Developments
    Table 160. Chanelle Pharma Corporation Information
    Table 161. Chanelle Pharma Description and Major Businesses
    Table 162. Chanelle Pharma Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. Chanelle Pharma Frovatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Chanelle Pharma Recent Developments
    Table 165. Key Raw Materials Lists
    Table 166. Raw Materials Key Suppliers Lists
    Table 167. Frovatriptan Distributors List
    Table 168. Frovatriptan Customers List
    Table 169. Frovatriptan Market Trends
    Table 170. Frovatriptan Market Drivers
    Table 171. Frovatriptan Market Challenges
    Table 172. Frovatriptan Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Frovatriptan Product Picture
    Figure 3. Global Frovatriptan Market Share by Type in 2021 & 2028
    Figure 3. Hospital Product Picture
    Figure 4. Drug Store Product Picture
    Figure 5. Global Frovatriptan Market Share by Application in 2021 & 2028
    Figure 6. Menstrual Migraines
    Figure 7. Migraine with Aura
    Figure 8. Migraine without Aura
    Figure 9. Frovatriptan Report Years Considered
    Figure 10. Global Frovatriptan Sales 2017-2028 (K Units)
    Figure 11. Global Frovatriptan Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Frovatriptan Revenue 2017-2028 (US$ Million)
    Figure 13. Global Frovatriptan Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Frovatriptan Sales Market Share by Region (2017-2022)
    Figure 15. Global Frovatriptan Sales Market Share by Region (2023-2028)
    Figure 16. North America Frovatriptan Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Frovatriptan Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Frovatriptan Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Frovatriptan Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Frovatriptan Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Frovatriptan Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Frovatriptan Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Frovatriptan Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Frovatriptan Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Frovatriptan Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Frovatriptan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Frovatriptan in the World: Market Share by Frovatriptan Revenue in 2021
    Figure 28. Global Frovatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Frovatriptan Sales Market Share by Type (2017-2028)
    Figure 30. Global Frovatriptan Revenue Market Share by Type (2017-2028)
    Figure 31. Global Frovatriptan Sales Market Share by Application (2017-2028)
    Figure 32. Global Frovatriptan Revenue Market Share by Application (2017-2028)
    Figure 33. North America Frovatriptan Sales Market Share by Type (2017-2028)
    Figure 34. North America Frovatriptan Revenue Market Share by Type (2017-2028)
    Figure 35. North America Frovatriptan Sales Market Share by Application (2017-2028)
    Figure 36. North America Frovatriptan Revenue Market Share by Application (2017-2028)
    Figure 37. North America Frovatriptan Sales Share by Country (2017-2028)
    Figure 38. North America Frovatriptan Revenue Share by Country (2017-2028)
    Figure 39. United States Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Frovatriptan Sales Market Share by Type (2017-2028)
    Figure 42. Europe Frovatriptan Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Frovatriptan Sales Market Share by Application (2017-2028)
    Figure 44. Europe Frovatriptan Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Frovatriptan Sales Share by Country (2017-2028)
    Figure 46. Europe Frovatriptan Revenue Share by Country (2017-2028)
    Figure 47. Germany Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 48. France Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Frovatriptan Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Frovatriptan Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Frovatriptan Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Frovatriptan Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Frovatriptan Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Frovatriptan Revenue Share by Region (2017-2028)
    Figure 58. China Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 61. India Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Frovatriptan Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Frovatriptan Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Frovatriptan Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Frovatriptan Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Frovatriptan Sales Share by Country (2017-2028)
    Figure 72. Latin America Frovatriptan Revenue Share by Country (2017-2028)
    Figure 73. Mexico Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Frovatriptan Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Frovatriptan Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Frovatriptan Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Frovatriptan Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Frovatriptan Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Frovatriptan Revenue Share by Country (2017-2028)
    Figure 82. Turkey Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Frovatriptan Revenue (2017-2028) & (US$ Million)
    Figure 85. Frovatriptan Value Chain
    Figure 86. Frovatriptan Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed